abiyz 3sy93 rdtnr h4572 8ihy9 5brka 7nbf8 28rh7 e292b r75f5 rdb23 br4t5 5re6z dtty4 r3rrn s6ihb b2eek 7f5z4 zre5h 485is y4e9f Abandoned Headquarters in Lincolnshire, IL |

Abandoned Headquarters in Lincolnshire, IL

2022.01.19 04:54 HHPhotographyWI Abandoned Headquarters in Lincolnshire, IL

Abandoned Headquarters in Lincolnshire, IL submitted by HHPhotographyWI to AbandonedPorn [link] [comments]

2022.01.19 04:54 Tree_forth677 Koishi is wearing a scarf

submitted by Tree_forth677 to Koishi_Komeiji [link] [comments]

2022.01.19 04:54 Xill_K47 The KN-44 has a sick holding stance

The KN-44 has a sick holding stance submitted by Xill_K47 to CallOfDutyMobile [link] [comments]

2022.01.19 04:54 kucFThePopulation Stone Hatchet Near the Native Burial.. A Problem I’m Having.

I’m on my road to Legend of the West Platinum Trophy and finally hit my first bump in the road.. I can’t find the Stone Hatchet even though I have an active GTA Online account. Has anyone else had this problem and found a fix for it? Do you have to obtain the hatchet in GTA Online?
submitted by kucFThePopulation to reddeadredemption [link] [comments]

2022.01.19 04:54 San__Ti lol lmao

submitted by San__Ti to Eve [link] [comments]

2022.01.19 04:54 aerospaghetti I lost the USB connector of my Microsoft explorer mini mouse 1363

Hi! Does anyone know if there's a way I can connect the mouse to a computer without the USB stick? And can I do it with a MacBook Pro? Thanks :)
submitted by aerospaghetti to microsoft [link] [comments]

2022.01.19 04:54 notmanydips Sigh.

Sigh. submitted by notmanydips to Butterflies [link] [comments]

2022.01.19 04:54 Seppe_Knaepen My thoughts on Activision Blizzard acquisition by Microsoft

Hello everyone. I wanted to share my thoughts on the latest acquisition by Microsoft. I don't want to minamalize it but I think that Sony shouldn't panic nor that Sony needs to make a big acquisition.
In my opinion the best thing that Sony can do is invest in their existing studios and expand these studios so that their biggest studios like Insomniac, Naughty Dog, Guerrilla Games, Santa Monica, Sucker Punch, ... can develop games every two-three years. Like this they can bring back older beloved IP's, create new IP's and continue the current IP's. I know that for example Naught Dog already tried this and it didn't work in the past, but if you see what Insomniac can achieve (Spider-Man, Ratchet and Clank, Miles Morales, Spider-Man 2, Wolverine all in a couple of years) I think it's worth a try.
I also think they should invest in relationships with third party developers. They should support smaller developers like ember labs (studio behind Kena) and if they do well, Sony can acquire them. That's why I like the Sony acquisitions of last year. Sony also can work together with bigger developers for the development of second party games. This is something that Sony is already doing in recent years but they can increase this. I would for example love to see a doctor Strange game by Remedy in the same universe as Spider-Man and Wolverine as a playstation exclusive.
I also think that Sony should make a few fps games and multiplayer games. I don't play these kind of games but I know they are popular. Sony should still be focused on the story driven games that they are familiar with but I think exclusive fps games and multiplayer games can be a nice addition. For these kind of games they can also work together with third party developers (for example Deviation Games).
What do you think about this? I also want to excuse me for my English because I'm not a native speaker and my English isn't that good.
submitted by Seppe_Knaepen to playstation [link] [comments]

2022.01.19 04:54 Fluid-Resource-9069 Is Rafe Judkins trying to copy an ideas from GoT?

submitted by Fluid-Resource-9069 to WheelofTimeSeries [link] [comments]

2022.01.19 04:54 chicagojournal 6 of the 9 people shot Tuesday were teenagers or younger

6 of the 9 people shot Tuesday were teenagers or younger submitted by chicagojournal to chicagojournal [link] [comments]

2022.01.19 04:54 AdventurousAd8839 It always start with donuts 🍩

It always start with donuts 🍩 submitted by AdventurousAd8839 to blender [link] [comments]

2022.01.19 04:54 Kitchen-Vanilla6169 [ITE] Nitec to yr 2 hnitec

So apparently I managed to get into a course in nitec, but I feel like I might not like as much as some course in hnitec. So my question here is, is it possible to go to a completely unrelated course in hnitec and its in yr 2? Will I be joining a existing class and will I be missing out on anything? Or it is completely new in yr 2.
submitted by Kitchen-Vanilla6169 to SGExams [link] [comments]

2022.01.19 04:54 Shay_Slazy Dire need of help

Dire need of help
I have been working in this project for a bit but it won't let me back in.

Help me please? Thank you so much!
submitted by Shay_Slazy to unrealengine [link] [comments]

2022.01.19 04:54 KINGAR_Gaming NFT giveaway!! Just join discord (in comments) and paste address.

NFT giveaway!! Just join discord (in comments) and paste address. submitted by KINGAR_Gaming to NFTsMarketplace [link] [comments]

2022.01.19 04:54 el_loud_nigra My right arm is larger than the left

Or at least i think so. But it has always been like this
Is it common?
submitted by el_loud_nigra to teenagers [link] [comments]

2022.01.19 04:54 simpleaccountname Where do I find charity bins in Geelong?

Was hoping to drop off a few bags of clothes. Can't drop them in the stores when they're opem because of work so Ive been looking for those charity bins somI can just drop off anytime.
submitted by simpleaccountname to Geelong [link] [comments]

2022.01.19 04:54 SuddenMary546 Does anyone know why Chocolate Ice Cream is so expensive now?

I don't remember this item being worth like 50k before I went into hiatus...Is there a reason why?
submitted by SuddenMary546 to neopets [link] [comments]

2022.01.19 04:54 Overall-Mouse-8665 Anyone feel like a visitor?

Hey! My kids and I were exposed to Covid and Im grumpy. We're in iso. Anyone feel like having a visitor? Id love to go to Northern Hemi if possible :)
submitted by Overall-Mouse-8665 to AnimalCrossingNewHor [link] [comments]

2022.01.19 04:54 ChonkBonko I think I might be Biromantic… I need advice.

Hey everyone. I’m a straight 19 year old male. I’m only sexually attracted to women, but as of recently I’ve been friends with this guy.
The more Ive talked to him the more I realized I have the capacity to be romantically attracted to men.
I’m thinking about talking to him about but I’m scared of what he’ll say. Any thoughts?
submitted by ChonkBonko to lgbt [link] [comments]

2022.01.19 04:54 PuzzleheadedFill5778 How will a team of giants fare in the Premier League?

How will a team of giants fare in the Premier League? Inspired by some of the great novelty posts here, I decided to try one of my own. How would a team of giants fare in the PL? With tall strikers like Benjamin Sesko and Lorenzo Lucca proving the meta this year, it got me wondering how a team of 11 giants would get on. I'm also interested to try out a defensive, route one tactic and see where it takes us. So let's do it!

The first thing to do was choose a team. I went with Burnley; as their club vision aligns well with our plan - play defensive and direct football. Next, we need some players. After gutting their squad completely, I spent some time debating over the best way to do this.

This is where things got a bit more interesting. I didn't want to just go purely with the tallest players for each position, as they'll lack the quality needed to be competitive. However, I also didn't just want the best big players available either. For that reason, we won't be using the likes of Van Dijk, Haaland or even Courtois in goal, but I have tried to keep the team around mid table quality. So let's meet the big men!
Altay Bayindir represents real quality in goal, while Vanja Milinkovic-Savic (yes, he's Sergej's brother) is also a quality back up. More importantly, they're 6'6 and 6'8 respectively, and both good at kicking the ball long, which we'll be doing lots of.
A healthy 8 centre backs in the squad, including 6'7 monsters Dan Burn and Jake Cooper. They won't all be playing centre back, of course, with Maksimovic and Akpoguma operating at RB, while Ajer will be our DM with Soler as his cover. There's some more logic to the madness here - Maksimovic and Akpoguma have 13 and 15 respectively for long throws, which should prove another useful weapon. That's also a factor for our choice of left backs, as Mitchell Dijks scores a 14 for long throws, while Charalampos Lykogiannis (try saying that after you've had a few!) not only has a 15 for long throws, but also a 16 for free kicks and 14 for corners. Lovely stuff, and that makes him for him only being a measly 6'3.
Four players to compete for our 2 CM spots - Soucek is likely to be one of our star men and will play a B2B role, with the master of flinging elbows Marouane Fellaini providing covering. Gravenberch - another 6'3 midget - makes it into the squad as our first choice LCM as he's both a potential star and a decent right footed option for corners and free kicks, while Anton Stach will provide cover and hopefully come off the bench to help us shut up shop late in games.
Finally, we've got 6 options up front. Wout Weghorst and Milan Duric bring more experience, while there's boat loads of potential between the other 4 options. I'm sure we won't keep them all happy all year, but let's see who shines and who doesn't. That brings us to our tactics. Or, should I say, tactic.
Park the bus with a few tweaks; we won't be passing into space and our goalie will be looking to kick it long to one of our target men. Our left back will have a bit more freedom to go forward, while we're going to experiment with 2 target men and a CF. Wout Weghorst and Sesko will fill the central role, while the 4 others will play as target men. Our secondary tactic won't exist. I may make some slight tweaks during matches, but generally speaking this will be our plan A, B and C. Sit back and hoof it long.
Finally, let's meet the man charged with taming all of these beasts.
Meet Frank Wankah. Taking his first job at 72 years old, Mr. Wankah stands at 7'1 and will stand for no nonsense. I'm sure he'd have landed a much fancier job in La Liga if he was called Franque Wankéh, but he'll soon show the world what they're missing out on. Frank's first point of order is to have all the full backs start working on developing flat long bullet throws, as well as changing the training schedule to include significantly more set piece work. Team cohesion is abysmal, which you'd expect given I've released the entire Burnley squad, including the youth teams, and chucked in 22 new players, so there's as much team bonding as possible, too.

Interestingly, all of our new players are listed under our transfer tab and assigned values; and we've got a squad worth exactly £100M. I feel comfortable I've made the team a decent level, not too many stars but hopefully we shouldn't struggle either. The board are only expecting us to "fight bravely against relegation" but me know where you think these guys will finish. I predict a slow start due to the lack of cohesion but hope we'll pull up some trees once we get rolling.
With set pieces all set up - including all our throw ins getting launched long in to the box - and our captain and vice captain selected in Tyrone Mings and Kristoffer Ajer, all that's left to do is breeze through some pre season friendlies, hopefully build some cohesion and see how the team gets on! And, of course, Mr. Wankah needs to attend a press conference to be officially unveiled as the new Burnley boss.
Burnley. We're fucking massive.
submitted by PuzzleheadedFill5778 to footballmanagergames [link] [comments]

2022.01.19 04:54 SituationLive4406 $IMMX CTB AVG 225% APR with 100% utilization 4.12M share float - Shares on Loan 670K all from Ortex Data as of 01-18-22

IMMIX Biopharma (IMMX) Looks Like it has Plenty of Room to Grow its Value
Good day everyone,
Immix Biopharma, Inc. (NASDAQ: IMMX) a biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases.
After closing at $5.84/share in the Friday session, IMMX shares opened lower today at $5.55. The market indices are struggling this morning and we hope that will turn around. In the first 30 minutes of trading IMMX share are above the open but lag the prior sessions close.
IMMX is not the only development/clinical stage company with a novel platform for cancer treatment. I looked at a few of the others and came to two conclusions and maybe you will agree:
I think the IMMX SMARxT Platform has more potential.
IMMX has a lot of room to grow its value.
C4 Therapeutics (CCCC) MV $1.33B
Adaptimmune Therapeutics (ADAP) MV $515M
Immix Biopharma (IMMX) MV $44M
Biolata (BCAB) MV $465M
Upcoming event
An IMMX Investors Day Event, will be held on February 1, 2022, and the launch of an online Q&A platform for all shareholders to submit questions in advance. IMMX shareholders can submit and upload questions to be answered at the event. To submit questions, please visit https://immixbio.com/QA. The Q&A platform will remain open until 5:00pm ET on Thursday, January 20. The live webcast will be available on the Investor Relations website at https://immixbio.com/IR. Following the event, a replay of the event, as well as a transcript, will be available on the same website.
To me, hosting a Q&A session so soon after their IPO indicates a high level of confidence.
IMMX shares exploded two weeks ago and have maintained their higher pricing level. Why?
Immix Biopharma, Inc. (NASDAQ: IMMX) is a clinical-stage biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases.
Current price $5.81/share (as of market close 1-18-22)
We wanted to report on IMMX because it’s a new IPO in the biopharma sector and we want to explore their potential. The company announced that its shares began trading on the NASDAQ on December 16th and the IPO closed on December 20th with an offering of 4,200,000 shares of its common stock at a price of $5.00 per share, for gross proceeds of $21M.
The IPO is less that a month old and like often happens, the company shares declined over the first couple weeks to under $3.50/share. On January 3rd the company announced its lead product candidate, IMX-110 was granted Rare Pediatric Disease (RPD) designation by the Food and Drug Administration for the treatment of pediatric cancer.
IMMX shares more than doubled on the news, closed that day at $5.78/share and have remained near that price range since. A quick check of the IMMX stock chart will show the narrow range the shares have traded in for the past two weeks. Will the company value stay in this narrow range? I think not, I believe it’s going higher and what I say below is why.
Firstly, IMMX has a tiny share structure (7.5M outstanding and only 1.29M in the float) and insiders own 44.6% of the outstanding shares. Altium Capital Management is already in for an 8.27% stake. Competition for IMMX shares is intensifying.
As you read about the IMMX platform below, keep in mind that as of this writing, the company market value is less that $50M and compare that to other companies you know of with promising oncology treatments in development.
The second reason interest is growing in IMMX shares is their novel technology. IMMX is developing a new class of Tissue-Specific Therapeutics, or TSTx, which they believe will replace first-line therapies across a multitude of oncology indications.
That press release on January 3rd opened investor’s eyes to the IMMX cancer treatment technology. It’s new, novel, and quite amazing. As investor awareness grows, I believe the company will grow. To me, it seems like the FDA is already looking favorably toward the IMMX technology.
Their SMARxT Platform produces Tissue-Specific Therapies, which in cancer target all three components (1. cancer associated fibroblasts, 2. tumor-associated macrophages/immune cells, and 3. cancer itself), of the TME simultaneously, severing the critical lifelines between the tumor and its metabolic support.
You will learn more about the IMMX SMARxT Platform by visiting the resources I’ve listed below but, briefly, the IMMX technology starves a cancer tumor of the nutrients it needs to survive and grow, effectively killing it.
Just last Wednesday the company informed that “ImmixBio IMX-110 Produced 50% Positive Response Rate in First-Line-Therapy-Resistant Cancer, Surpassing the Standard of Care in Mice Study.” That 50% is an impressive positive response rate. The data was generated after 1 cycle of treatment as a monotherapy in first line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study. Clinical treatment for STS, is a $3 billion market expected to grow to $6.5 billion by 2030.
Just to underscore the significance of the animal study above, Doxorubicin, a cancer treatment that IMMX may compete with, one with over $1B in revenues, had a response rate of 0% after 1 cycle of treatment in the same study.
Watch this short video that describes the function of their IMX-110 product and review the presentation linked below to familiarize yourself with this new approach to cancer treatment. I’m certain that savvy investors are doing it.
In the chart below you can see the three products in development at IMMX. As a part of your due diligence, you can review the company presentation.
IMMX was incorporated in California in 2012 so they have been developing their technology for a while. They also have a wholly owned Australian subsidiary, Immix Biopharma Australia Pty Ltd., to conduct various pre-clinical and clinical activities for the development of product candidates.
The potential for growth in value at IMMX is not only likely, but I also believe it could be exponential. As you study their SMARxT Platform you may understand why the competition for that tiny 1.29M share float is getting competitive.
submitted by SituationLive4406 to pennystocks [link] [comments]

2022.01.19 04:54 Greenverse_Studio Some characters I made for RPG companies.

Some characters I made for RPG companies. submitted by Greenverse_Studio to DungeonsAndDragons [link] [comments]

2022.01.19 04:54 secretjitterbug Det är covid times. Vad gör ni när tristessen blir för stor?

Vissa dagar känns det bara som man sprängs av tristess av rutinen, samma miljö och samma allt, dag in och dag ut. Detta särskilt för oss som jobbar hemifrån. Bortom att panikflytta eller skaffa nya möbler, hur gör ni för att få till lite variation i tillvaron?
submitted by secretjitterbug to sweden [link] [comments]

2022.01.19 04:54 pancakes492719 being queer meaning ?

i (f19) was hanging out with my crush (19) when he said that he’s queer …
not sure what he means by that and i didn’t push it since he’s not my boyfriend …
does queer mean gay or bi??
i don’t mean to offend anyone
submitted by pancakes492719 to relationship_advice [link] [comments]

2022.01.19 04:54 0ne--time The Annoying cycle of Tdb2

I get into lead dungeon. Drop out to White because someone Rushed purples, With an OP overused strategy, Lose in white Alot And Get down to 32 - 35 Trophies. I Try a different strategy, Lose, Move Back up, cycle repeats
I just hate the fact people can just easily use the same overused strat Over, and Over, and Over again. It just gets boring when you cant do the same.
And I cant grind, Because People kill me too fast to get any Exp So I Get the upgrades in a really slow process. And After a session of grinding getting under 6k, Im back in White!
submitted by 0ne--time to battles2 [link] [comments]